7 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Showing 7 of 7 clinical reviews.
Evidence-based guide to trazodone pharmacogenomics and dosing considerations specific to Hispanic and Latino populations, including CYP2D6 and CYP3A4 variant frequencies, metabolic comorbidities, and clinical monitoring.
East Asian patients metabolize trazodone differently due to CYP2C19 and CYP2D6 genetic variants. Learn how these differences affect safety, sedation risk, and optimal starting doses.
A clinician-reviewed guide to trazodone pharmacogenomics, dosing, and safety considerations specific to Hispanic and Latino patients, including CYP2D6 variants, diabetes risk, and orthostatic hypotension data.
A clinical review of trazodone efficacy differences, pharmacogenomic variation, and dosing considerations in Black and African ancestry patients, with cited RCT subgroup data and PharmGKB evidence.
A clinical deep-dive into why trazodone may work differently in South Asian patients, covering CYP2D6 pharmacogenomics, ethnicity-stratified trial data, cardiovascular risk considerations, and practical dosing guidance reviewed by HealthRX.com physicians.
A clinical review of trazodone pharmacogenomics, dosing considerations, and safety differences in Black and African ancestry patients, with ethnicity-stratified data and guideline citations.
A clinician-reviewed guide to trazodone dosing in South Asian patients, covering CYP2D6 and CYP3A4 pharmacogenomics, cardiovascular risk at lower BMI, and ethnicity-stratified evidence from PharmGKB and published trials.